BIOMAT Database Logo BIOMAT Database Logo

Trends in meningococcal disease in Italy 1987. 1989

T Stroffolini, and C M Curianó, and M E Congiu, and M Occhionero, and P Mastrantonio Gianfrilli

Meningococcal disease in Italy decreased 29% in 1987 from the previous year. The highest number of cases was seen in the 1-4 year-old age group (27%). The frequency in army recruits was 5/100,000, still higher than the 0.57/100,000 in the general population, but less than the 7/100,000 reported in the previous year. Sixty-three percent of the isolates belonged to serogroup C while serogroup B constituted 25%. The proportion of strains resistant to sulphonamides was 52.6%. Six strains were resistant to rifampin and none to minocyclin. No secondary cases occurred. These results are consistent with the trends reported in Italy in 1986. There were two findings of interest in 1987: the absence of secondary cases, attributable to the appropriate administration of chemoprophylaxis; and the decrease in military cases, reflecting the use of bivalent serogroup (A + C) meningococcal polysaccharide vaccine in all new military recruits since January 1987.

UI MeSH Term Description Entries
D007558 Italy A country in southern Europe, a peninsula extending into the central Mediterranean Sea, northeast of Tunisia. The capital is Rome. Sardinia
D008585 Meningitis, Meningococcal A fulminant infection of the meninges and subarachnoid fluid by the bacterium NEISSERIA MENINGITIDIS, producing diffuse inflammation and peri-meningeal venous thromboses. Clinical manifestations include FEVER, nuchal rigidity, SEIZURES, severe HEADACHE, petechial rash, stupor, focal neurologic deficits, HYDROCEPHALUS, and COMA. The organism is usually transmitted via nasopharyngeal secretions and is a leading cause of meningitis in children and young adults. Organisms from Neisseria meningitidis serogroups A, B, C, Y, and W-135 have been reported to cause meningitis. (From Adams et al., Principles of Neurology, 6th ed, pp689-701; Curr Opin Pediatr 1998 Feb;10(1):13-8) Meningitis, Neisseria,Neisseria Meningitis,Meningitis, Meningococcal, Serogroup A,Meningitis, Meningococcal, Serogroup B,Meningitis, Meningococcal, Serogroup C,Meningitis, Meningococcal, Serogroup W-135,Meningitis, Meningococcal, Serogroup W135,Meningitis, Meningococcal, Serogroup Y,Meningitis, Meningococcic,Meningococcal Meningitis, Serogroup A,Meningococcal Meningitis, Serogroup B,Meningococcal Meningitis, Serogroup C,Meningococcal Meningitis, Serogroup W-135,Meningococcal Meningitis, Serogroup W135,Meningococcal Meningitis, Serogroup Y,Serogroup A Meningococcal Meningitis,Serogroup B Meningococcal Meningitis,Serogroup C Meningococcal Meningitis,Serogroup W-135, Meningococcal Meningitis,Serogroup W135, Meningococcal Meningitis,Serogroup Y, Meningococcal Meningitis,Meningococcal Meningitis,Meningococcal Meningitis, Serogroup W 135,Neisseria Meningitides,Serogroup W 135, Meningococcal Meningitis
D009345 Neisseria meningitidis A species of gram-negative, aerobic BACTERIA. It is a commensal and pathogen only of humans, and can be carried asymptomatically in the NASOPHARYNX. When found in cerebrospinal fluid it is the causative agent of cerebrospinal meningitis (MENINGITIS, MENINGOCOCCAL). It is also found in venereal discharges and blood. There are at least 13 serogroups based on antigenic differences in the capsular polysaccharides; the ones causing most meningitis infections being A, B, C, Y, and W-135. Each serogroup can be further classified by serotype, serosubtype, and immunotype. Diplokokkus intracellularis meningitidis,Meningococcus,Micrococcus intracellularis,Micrococcus meningitidis,Micrococcus meningitidis cerebrospinalis,Neisseria weichselbaumii
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012703 Serotyping Process of determining and distinguishing species of bacteria or viruses based on antigens they share. Serotypings
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D015331 Cohort Studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. Birth Cohort Studies,Birth Cohort Study,Closed Cohort Studies,Cohort Analysis,Concurrent Studies,Historical Cohort Studies,Incidence Studies,Analysis, Cohort,Cohort Studies, Closed,Cohort Studies, Historical,Studies, Closed Cohort,Studies, Concurrent,Studies, Historical Cohort,Analyses, Cohort,Closed Cohort Study,Cohort Analyses,Cohort Studies, Birth,Cohort Study,Cohort Study, Birth,Cohort Study, Closed,Cohort Study, Historical,Concurrent Study,Historical Cohort Study,Incidence Study,Studies, Birth Cohort,Studies, Cohort,Studies, Incidence,Study, Birth Cohort,Study, Closed Cohort,Study, Cohort,Study, Concurrent,Study, Historical Cohort,Study, Incidence

Related Publications

T Stroffolini, and C M Curianó, and M E Congiu, and M Occhionero, and P Mastrantonio Gianfrilli
Trends in meningococcal disease in Italy in 1988.
March 1990, Public health,
T Stroffolini, and C M Curianó, and M E Congiu, and M Occhionero, and P Mastrantonio Gianfrilli
Meningococcal disease in Italy.
July 1989, The Journal of infection,
T Stroffolini, and C M Curianó, and M E Congiu, and M Occhionero, and P Mastrantonio Gianfrilli
Trends and variations in the epidemiology of meningococcal disease in Kuwait 1987-2013.
January 2015, Journal of infection and public health,
T Stroffolini, and C M Curianó, and M E Congiu, and M Occhionero, and P Mastrantonio Gianfrilli
Trends in meningococcal disease.
April 1970, The Journal of infectious diseases,
T Stroffolini, and C M Curianó, and M E Congiu, and M Occhionero, and P Mastrantonio Gianfrilli
Trends in meningococcal disease.
May 1989, The Journal of the Oklahoma State Medical Association,
T Stroffolini, and C M Curianó, and M E Congiu, and M Occhionero, and P Mastrantonio Gianfrilli
Trends in meningococcal disease.
April 1970, The Journal of infectious diseases,
T Stroffolini, and C M Curianó, and M E Congiu, and M Occhionero, and P Mastrantonio Gianfrilli
Trends in meningococcal disease.
November 1969, The Journal of infectious diseases,
T Stroffolini, and C M Curianó, and M E Congiu, and M Occhionero, and P Mastrantonio Gianfrilli
Meningococcal disease in Italy in 1989.
January 1992, European journal of epidemiology,
T Stroffolini, and C M Curianó, and M E Congiu, and M Occhionero, and P Mastrantonio Gianfrilli
Meningococcal disease in Italy in 1990.
October 1991, Microbiologica,
T Stroffolini, and C M Curianó, and M E Congiu, and M Occhionero, and P Mastrantonio Gianfrilli
Meningococcal disease in Canada: surveillance summary to 1987.
September 1989, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
Copied contents to your clipboard!